SLC5A2 and diabetic ketoacidosis: Although SGLT2 inhibitors have several organ-protective effects, [5, 6] they are associated with an increased incidence of side effects, including dehydration, dry mouth, urinary tract infections, and euglycemic diabetic ketoacidosis (eDKA), the most severe adverse effect of the drug.